APOA1 and obesity due to melanocortin 4 receptor deficiency: A direct anti-obesity effect on apoAI and its mimetic peptide has also been recently reported whereby HDL treatment increased adipose tissue expenditure through attainment of brown adipocyte phenotype in white adipose tissue (31).